Skip to content

Drug interactions

Ramelteon + Zafirlukast

Severity: Minor

Ramelteon and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ramelteon is metabolized mainly by CYP1A2, with minor roles for CYP2C and CYP3A4. Zafirlukast's weak inhibition of these enzymes is unlikely to alter ramelteon effects meaningfully.

What this interaction means in plain words

Ramelteon and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ramelteon belongs to Central Nervous System; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Possible weak inhibition of CYP2C9 and CYP3A4 by zafirlukast reducing ramelteon clearance.

What to do

No adjustment is needed. Monitor for increased daytime drowsiness or dizziness.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ramelteon and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ramelteon with Zafirlukast?

MediHelp rates the interaction as minor. Ramelteon and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ramelteon is metabolized mainly by CYP1A2, with minor roles for CYP2C and CYP3A4. Zafirlukast's weak inhibition of these enzymes is unlikely to alter ramelteon effects meaningfully.

How serious is the interaction between Ramelteon and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment is needed. Monitor for increased daytime drowsiness or dizziness.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in